A year into funding cuts, where do NIH researchers stand?
“We’re not signaling to this next generation of early-career researchers that there is a stable, predictable opportunity for careers in science that are based on government funding,” Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, told Healthcare Brew. “Talent follows stability.”
Healthcare Brew - April 22, 2026